Innovative Therapy Reverses Lung and Nerve Damage From COVID-19

Exosome therapy offers a cutting-edge approach for COVID-19’s neurological, mental, and cardiac effects.
Innovative Therapy Reverses Lung and Nerve Damage From COVID-19
PeopleImages.com - Yuri A/Shutterstock
|Updated:
0:00

Many of us who have been infected with the COVID-19 virus face long-term health challenges, including lung nodules, severe complications, and surgery. Current treatments for these long-term effects are still limited. This article introduces the potential of exosome therapy, a cutting-edge treatment, to address COVID-19 syndrome, particularly its neurological and mental health aspects and its benefits for the heart and lungs.

Dr. Philip W. Askenase, a professor of immunology at the Yale University School of Medicine, proposed in an academic journal that extracellular vesicle therapy should be used to treat the main central nervous system symptoms of COVID-19 syndrome. Extracellular vesicles are particles released by cells, and exosomes are one type of extracellular vesicles.

Vascular and Nerve Damage from COVID-19

Up to 30 percent of people infected with COVID-19 may develop long COVID, a complex condition with a wide range of symptoms. Common symptoms include extreme fatigue, shortness of breath, brain fog, cognitive impairment, changes in taste or smell, and gastrointestinal issues.
Jingduan Yang
Jingduan Yang
M.D.
Dr. Jingduan Yang is a board-certified psychiatrist and fifth-generation classical Chinese medicine physician whose work bridges Western psychiatry, functional medicine, and ancient healing traditions. He is the creator of the ACES Model of Health and Medicine—a four-dimensional framework spanning anatomy, chemistry, energy, and spirit—and the author of “Facing East” and “Clinical Acupuncture and Ancient Chinese Medicine.” As a principal founder of the Northern School of Medicine and Health Sciences, he advances whole-person care grounded in science, ethics, and humanity.